Indoxyl sulphate‐initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor‐erythroid‐2‐related factor 2

Abstract

AbstractIn the last decade, extensive attention has been paid to the uremic toxin indoxyl sulphate (IS) as an inducer of cardiac fibroblast (cFib) activation and cardiac fibrosis in chronic kidney disease. At cellular level, IS engages aryl hydrocarbon receptor (AhR) and regulates many biological functions. We analysed how AhR inhibition by CH‐223191 (CH) and overexpression of non‐functional (dominant negative, DN) nuclear factor‐erythroid‐2‐related factor 2 (NRF2), a transcription factor recruited by AhR, modulate the response of neonatal mouse (nm) cFib to IS. We also evaluated nm‐cardiomyocytes after incubation with the conditioned medium (CM) of IS±CH‐treated nm‐cFib. IS induced activation, collagen synthesis, TLR4 and–downstream–MCP‐1, and the genes encoding angiotensinogen, angiotensin‐converting enzyme, angiotensin type 1 receptor (AT1r) and neprilysin (Nepr) in nm‐cFib. CH antagonized IS‐initiated nm‐cFib activation, but did not affect or even magnified the other features. IS promoted NRF2 nuclear translocation and expression the NRF2 target Nqo1. Both pre‐incubation with CH and transfection of DN‐NRF2 resulted in loss of NRF2 nuclear localization. Moreover, DN‐NRF2 overexpression led to greater TLR4 and MCP‐1 levels following exposure to IS. The CM of IS‐primed nm‐cFib and to a larger extent the CM of IS+CH‐treated nm‐cFib upregulated AT1r, Nepr and TNFα and myostatin genes in nm‐cardiomyocytes. Hence, IS triggers pro‐inflammatory activation of nm‐cFib partly via AhR, and AhR‐NRF2 counteract it. Strategies other than AhR inhibition are needed to target IS detrimental actions on cardiac cells.